# Active MMP-8 in Oral Fluid for the Detection of Oral and Oropharyngeal Cancer

> **NCT06701058** · — · COMPLETED · sponsor: **Helsinki University Central Hospital** · enrollment: 107 (actual)

## Conditions studied

- Oropharyngeal Cancers
- Biomarker in Early Diagnosis
- Oral Cancer , Oral Squamous Cell Carcinoma, Oral Cavity Cancer
- Periodontal Diseases

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT06701058
- **Lead sponsor:** Helsinki University Central Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2022-03-28
- **Primary completion:** 2024-09-01
- **Final completion:** 2024-09-18
- **Target enrollment:** 107 (ACTUAL)
- **Last updated:** 2024-11-22

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06701058

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06701058, "Active MMP-8 in Oral Fluid for the Detection of Oral and Oropharyngeal Cancer". Retrieved via AI Analytics 2026-07-16 from https://api.ai-analytics.org/clinical/NCT06701058. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*